Fatal pulmonary embolism following hip and knee replacement. A study of 2153 cases using routine mechanical prophylaxis and selective chemoprophylaxis

HIP International

Volumn 16, Issue 1, 2006, Pages 53-56

  Shepherd, Andrew ^a,b   Mills, C ^a  

^a NORTH DEVON DISTRICT HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Joint replacement; Pulmonary embolism; Thromboprophylaxis

Indexed keywords

ENOXAPARIN; WARFARIN;

ADULT; AGED; ARTICLE; AUTOPSY; CAUSE OF DEATH; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CORONER; DATA BASE; FATALITY; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MEDICAL RECORD; MOBILIZATION; PATIENT IDENTIFICATION; PHARMACY; POSTOPERATIVE CARE; QUANTITATIVE ANALYSIS; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

EID: 33744952449     PISSN: 11207000     EISSN: None     Source Type: Journal    
DOI: 10.5301/HIP.2008.4713     Document Type: Article

References (15)

1. Brenkel I, Cook R. Thromboprophylaxis in patients undergoing total hip replacement. Hosp Med 2003; 64: 281-7.
2. Ansari S, Warwick D, Ackroyd C, Newman J. Incidence of fatal pulmonary embolism after 1390 knee arthroplasties without routine prophylactic anticoagulation, except in high-risk cases. J Arthroplasty 1997; 12: 599-602.
3. Dahl OE, Aspelin T, Arnesen H, et al. Increased activation of coagulation and formation of late deep vein thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res 1995; 80: 299-306.
4. Warwick D, Williams MH, Bannister GC. Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg Br 1995; 77: 6-10.
5. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240-5.
6. Huber O, Bounameaux H, Borst F, Rohner A. Post-operative pulmonary embolism after hospital discharge. Arch Surg 1992; 127: 310-3.
7. Khaw FM, Moran CG, Pinder IM, Smith SR. Fatal pulmonary embolism after total knee replacement with no prophylactic anticoagulation. J Bone Joint Surg Br 1993; 75: 940-1.
8. Wroblewski BM, Siney PD, White R. Fatal pulmonary embolism after total hip arthroplasty: seasonal variation. Clin Orthop 1991; 276: 222-4.
9. Wood M, Mantilla C, Horlocker T, Schroeder M, Berry D, Brown M. Frequency of myocardial infarction, pulmonary embolism, deep vein thrombosis and death following primary hip or knee arthroplasty. Anesthesiology 2002; 96: 1140-6.
10. Parvizi J, Johnson BG, Rowland C, Ereth MH, Lewallen DG. Thirty-day mortality after elective total hip arthroplasty. J Bone Joint Surg Am 2001; 83: 1524-8.
11. Wroblewski BM, Siney PD, Fleming PA. Fatal pulmonary embolism after total hip arthroplasty: diurnal variation. Orthopaedics 1998; 21: 1269-71.
12. Warwick D, Harrison J, Glew D, Mitchelmore A, Peters TJ, Donovan J. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial. J Bone Joint Surg Am 1998; 80: 1158-66.
13. Stone MH, Limb D, Campbell P, Stead D, Culleton G. A comparison of intermittent calf compression and enoxaparin for thromboprophylaxis in total hip replacement. A pilot study. Int Orthop 1996; 20: 367-9.
14. Khan A, Emberson J, Dowd GS. Standardised mortality ratios and fatal pulmonary embolism rates following total knee replacement, J Knee Surg 2002; 15: 219-22.
15. Fender D, Harper WM, Thompson JR, Gregg PJ. Mortality and fatal pulmonary embolism after primary total hip replacement. Results from a regional hip register. J Bone Joint Surg Br 1997; 79: 896-9.